Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Rheumatology International
Published in: Rheumatology International 11/2015

01-11-2015 | Case Based Review - Cases with a Message

Bone and bone marrow involvement in sarcoidosis

Authors: Ralph Yachoui, Brian J. Parker, Thanhcuong T. Nguyen

Published in: Rheumatology International | Issue 11/2015

Login to get access

Abstract

Bone and bone marrow involvement in sarcoidosis have been infrequently reported. We aimed to describe the clinical features, radiological descriptions, pathological examinations, and outcomes of three patients with osseous sarcoidosis and one patient with bone marrow sarcoidosis seen at our institution. Our case series included fluorodeoxyglucose positron emission tomography descriptions in assessing the whole-body extent of sarcoidosis. In the era of advanced imaging, large bone and axial skeleton sarcoidosis lesions are more common than previously reported.
Literature
1.
Mayock RL, Bertrand P, Morrison CE et al (1963) Manifestations of sarcoidosis. analysis of 145 patients, with a review of nine series selected from the literature. Am J Med 35:67–89CrossRefPubMed
2.
3.
Thelier N, Assous N, Job-Deslandre C, Meyer O, Bardin T, Orcel P, Lioté F, Dougados M, Kahan A, Allanore Y (2008) Osteoarticular involvement in a series of 100 patients with sarcoidosis referred to rheumatology departments. J Rheumatol 35:1622–1628PubMed
4.
James DG, Neville E, Siltzbach LE (1976) A worldwide review of sarcoidosis. Ann N Y Acad Sci 278:321–334CrossRefPubMed
5.
Brackers de Hugo L, Ffrench M, Broussolle C, Seve P (2013) Granulomatous lesions in bone marrow: clinicopathologic findings and significance in a study of 48 cases. Eur J Intern Med 24:468–473CrossRefPubMed
6.
Yaghmai I (1983) Radiographic, angiographic and radionuclide manifestations of osseous sarcoidosis. RadioGraphics 3:375–396CrossRef
7.
Sparks JA, McSparron JI, Shah N, Aliabadi P, Paulson V, Fanta CH, Coblyn JS (2014) Osseous sarcoidosis: clinical characteristics, treatment, and outcomes–experience from a large, academic hospital. Semin Arthritis Rheum 44:371–379CrossRefPubMed
8.
Wilcox A, Bharadwaj P, Sharma OP (2000) Bone sarcoidosis. Curr Opin Rheumato. 12:321–330CrossRef
9.
Moore SL, Kransdorf MJ, Schweitzer ME, Murphey MD, Babb JS (2012) Can sarcoidosis and metastatic bone lesions be reliably differentiated on routine MRI? AJR Am J Roentgenol 198:1387–1393CrossRefPubMed
10.
Mostard RL, Prompers L, Weijers RE, van Kroonenburgh MJ, Wijnen PA, Geusens PP, Drent M (2012) F-18 FDG PET/CT for detecting bone and bone marrow involvement in sarcoidosis patients. Clin Nucl Med 37:21–25CrossRefPubMed
11.
Milman N, Lund JO, Graudal N, Enevoldsen H, Evald T, Nørgård P (2000) Diagnostic value of routine radioisotope bone scanning in a series of 63 patients with pulmonary sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 17:67–70PubMed
12.
13.
Yanardag H, Pamuk GE, Karayel T, Demirci S (2002) Bone marrow involvement in sarcoidosis: an analysis of 50 bone marrow samples. Haematologia (Budap) 32:419–425
14.
Ponce C, Gujral JS (2004) Renal failure and hypercalcemia as initial manifestations of extrapulmonary sarcoidosis. South Med J 97:590–592CrossRefPubMed
15.
Saliba WR, Elias MS (2005) Recurrent severe hypercalcemia caused by bone marrow sarcoidosis. Am J Med Sci 330:147–149CrossRefPubMed
Metadata
Title
Bone and bone marrow involvement in sarcoidosis
Authors
Ralph Yachoui
Brian J. Parker
Thanhcuong T. Nguyen
Publication date
01-11-2015
Publisher
Springer Berlin Heidelberg
Published in
Rheumatology International / Issue 11/2015
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-015-3341-y

Other articles of this Issue 11/2015

Rheumatology International 11/2015 Go to the issue

Review Article - Review Health Services

Polymyalgia rheumatica: strategies for efficient practice and quality assurance

Letter to the Editor - Rheumatology in the Past

Catherine of Aragon (1485–1536): the red malar rash of familial SLE in a Tudor red rose queen

Case Based Review - Cases with a Message

Colchicine–clarithromycin-induced rhabdomyolysis in Familial Mediterranean Fever patients under treatment for Helicobacter pylori

Case Based Review - Cases with a Message

Canakinumab efficacy and long-term tocilizumab administration in tumor necrosis factor receptor-associated periodic syndrome (TRAPS)

Case Based Review - Cases with a Message

Infliximab as a treatment option for patients with rheumatoid arthritis and primary biliary cirrhosis

Original Article - Observational Research

A European chart review study on early rheumatoid arthritis treatment patterns, clinical outcomes, and healthcare utilization
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits